NeuraSignal logo — company profile

NeuraSignal

Founded 2013 United States Los Angeles, United States 34 employees Series C AI, Analytics

General Information

Company Name NeuraSignal
Founded Year 2013
Location United States Los Angeles, United States +1
Employees 34
Industries AI, Analytics
Funding Stage Series C
Social

Get notified when NeuraSignal moves

Funding, new markets, leadership changes, hiring surges — one e-mail, only when something happens.

Free · no account needed

About NeuraSignal

NovaSignal is a biotechnology and healthcare startup based in the United States, founded in 2013. In a significant development, in 2023 NeuraSignal, Inc. acquired the business of NovaSignal, the original developer of NovaGuide. NeuraSignal is a medical technology company with a mission to save lives by unlocking the power of cerebral blood flow data. The company's FDA-cleared NovaGuide Intelligent Ultrasound combines non-invasive ultrasound, robotics, and artificial intelligence to assess cerebral hemodynamics in real time. This technology, combined with cloud computing and data analytics, supports physicians in their clinical decision making in several neurological conditions including stroke, traumatic brain injury, and dementia. In its last funding round, NovaSignal secured a noteworthy $37.00M Series C investment on 28 September 2021. The investors participating in this round were Alpha Edison and Reimagined Ventures. The company's continued focus on leveraging advanced technologies to improve diagnostics and treatment in the field of neurology positions it as an attractive opportunity for investors seeking to support innovations in the healthcare industry. For further information, visit www.NeuraSignal.com.

Taxonomy: cerebral blood flow, ultrasound technology, robotics, cloud computing, neurological conditions, stroke assessment, traumatic brain injury, dementia assessment, FDA-cleared, innovation, cerebral hemodynamics

No funding data available for NeuraSignal yet.

Get notified when NeuraSignal raises funding

NeuraSignal Alternatives & Competitors

NeuraSignal vs

Bobovue provides online detection of neurodevelopmental disorders, utilizing AI and machine learning...

NeuraSignal vs

Realizing Tomorrow's Potential.....Today!

123 employees
Education, Health Care
NeuraSignal vs
NEUROFIELDZ INC.
NEUROFIELDZ INC. United States

Crafting advanced brain imaging and neuron-monitoring devices to detect brain cancer, tumors, and ot...

Grant
2-10 employees
Biotechnology
Also compare with: NeuraSignal vs Regennova Regennova

FAQ About NeuraSignal

In 2023 NeuraSignal, Inc. acquired the business of NovaSignal, the original developer of NovaGuide. NeuraSignal is a medical technology company with a mission to save lives by unlocking the power of cerebral blood flow data. The company’s FDA-cleared NovaGuide Intelligent Ultrasound combines non-inv...
NeuraSignal was founded in 2013.
NeuraSignal is headquartered in Los Angeles, United States.
NeuraSignal operates in the following industries: AI, Analytics.
NeuraSignal has approximately 34 employees.
Top alternatives and competitors to NeuraSignal include bobovue, Cerebral Palsy of Westchester, NEUROFIELDZ INC., Regennova, LuSeed Vascular. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
NeuraSignal and bobovue are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Don't just browse. Track.

Signal Tracker monitors NeuraSignal and millions of companies for funding rounds, hiring surges, product changes, and 40+ signal types — so you never miss an opportunity.

One analytics cookie (Google Analytics). Cookie Policy